Pathogenesis of Sjögren's syndrome: What we know and what we should learn

Journal of Autoimmunity

Volumn 39, Issue 1-2, 2012, Pages 4-8

  Tzioufas, Athanasios G ^a   Kapsogeorgou, Efstathia K ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Autoimmune lesions; Epithelial cells; Pathogenesis; Salivary gland; Sj gren's syndrome

Indexed keywords

ADIPONECTIN; B CELL ACTIVATING FACTOR; CD40 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RANTES; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL EXPANSION; CELL HOMING; CELL INFILTRATION; CELL MATURATION; CELL SURVIVAL; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HUMAN; INNATE IMMUNITY; MACROPHAGE; MINOR SALIVA GLAND; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SJOEGREN SYNDROME; TH17 CELL;

AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; COMPLEMENT C4; CYTOKINES; EPITHELIAL CELLS; HUMANS; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME;

EID: 84862490927     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.01.002     Document Type: Article

References (80)

1. Moutsopoulos H.M. Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994, 72:162-165.
2. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002, 46:741-747.
3. Ramos-Casals M., Brito-Zeron P., Yague J., Akasbi M., Bautista R., Ruano M., et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2005, 44:89-94.
4. Skopouli F.N., Dafni U., Ioannidis J.P., Moutsopoulos H.M. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum 2000, 29:296-304.
5. Sutcliffe N., Inanc M., Speight P., Isenberg D. Predictors of lymphoma development in primary Sjogren's syndrome. Semin Arthritis Rheum 1998, 28:80-87.
6. Voulgarelis M., Dafni U.G., Isenberg D.A., Moutsopoulos H.M. Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's Syndrome. Arthritis Rheum 1999, 42:1765-1772.
7. Christodoulou M.I., Kapsogeorgou E.K., Moutsopoulos H.M. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun 2010, 34:400-407.
8. Christodoulou M.I., Kapsogeorgou E.K., Moutsopoulos N.M., Moutsopoulos H.M. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol 2008, 173:1389-1396.
9. Manoussakis M.N., Boiu S., Korkolopoulou P., Kapsogeorgou E.K., Kavantzas N., Ziakas P., et al. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjogren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheum 2007, 56:3977-3988.
10. Boumba D., Skopouli F.N., Moutsopoulos H.M. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjogren's syndrome. Br J Rheumatol 1995, 34:326-333.
11. Mitsias D.I., Tzioufas A.G., Veiopoulou C., Zintzaras E., Tassios I.K., Kogopoulou O., et al. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin Exp Immunol 2002, 128:562-568.
12. Bombardieri M., Barone F., Pittoni V., Alessandri C., Conigliaro P., Blades M.C., et al. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther 2004, 6:R447-R456.
13. Fox R.I., Kang H.I., Ando D., Abrams J., Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. J Immunol 1994, 152:5532-5539.
14. Koski H., Janin A., Humphreys-Beher M.G., Sorsa T., Malmstrom M., Konttinen Y.T. Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjogren's syndrome. Clin Exp Rheumatol 2001, 19:131-137.
15. Mason G.I., Hamburger J., Bowman S., Matthews J.B. Salivary gland expression of transforming growth factor beta isoforms in Sjogren's syndrome and benign lymphoepithelial lesions. Mol Pathol 2003, 56:52-59.
16. Nguyen C.Q., Hu M.H., Li Y., Stewart C., Peck A.B. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice. Arthritis Rheum 2008, 58:734-743.
17. Espinosa A., Dardalhon V., Brauner S., Ambrosi A., Higgs R., Quintana F.J., et al. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med 2009, 206:1661-1671.
18. Katsifis G.E., Rekka S., Moutsopoulos N.M., Pillemer S., Wahl S.M. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am J Pathol 2009, 175:1167-1177.
19. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 2002, 109:59-68.
20. Daridon C., Guerrier T., Devauchelle V., Saraux A., Pers J.O., Youinou P. Polarization of B effector cells in Sjogren's syndrome. Autoimmun Rev 2007, 6:427-431.
21. Jonsson R., Nginamau E., Szyszko E., Brokstad K.A. Role of B cells in Sjogren's syndrome-from benign lymphoproliferation to overt malignancy. Front Biosci 2007, 12:2159-2170.
22. Gerli R., Muscat C., Giansanti M., Danieli M.G., Sciuto M., Gabrielli A., et al. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjogren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. Br J Rheumatol 1997, 36:969-975.
23. Manoussakis M.N., Kapsogeorgou E.K. The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. J Autoimmun 2010, 35:219-224.
24. Mitsias D.I., Kapsogeorgou E.K., Moutsopoulos H.M. Sjogren's syndrome: why autoimmune epithelitis?. Oral Dis 2006, 12:523-532.
25. Kapsogeorgou E.K., Moutsopoulos H.M., Manoussakis M.N. A novel B7-2 (CD86) splice variant with a putative negative regulatory role. J Immunol 2008, 180:3815-3823.
26. Kapsogeorgou E.K., Moutsopoulos H.M., Manoussakis M.N. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J Immunol 2001, 166:3107-3113.
27. Spachidou M.P., Bourazopoulou E., Maratheftis C.I., Kapsogeorgou E.K., Moutsopoulos H.M., Tzioufas A.G., et al. Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren's syndrome. Clin Exp Immunol 2007, 147:497-503.
28. Daridon C., Devauchelle V., Hutin P., Le Berre R., Martins-Carvalho C., Bendaoud B., et al. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 2007, 56:1134-1144.
29. Ittah M., Miceli-Richard C., Eric Gottenberg J., Lavie F., Lazure T., Ba N., et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome. Arthritis Res Ther 2006, 8:R51.
30. Jonsson M.V., Szodoray P., Jellestad S., Jonsson R., Skarstein K. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J Clin Immunol 2005, 25:189-201.
31. Abu-Helu R.F., Dimitriou I.D., Kapsogeorgou E.K., Moutsopoulos H.M., Manoussakis M.N. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression. J Autoimmun 2001, 17:141-153.
32. Cohen J.J., Duke R.C., Fadok V.A., Sellins K.S. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992, 10:267-293.
33. Ohlsson M., Jonsson R., Brokstad K.A. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjogren's syndrome. Scand J Immunol 2002, 56:456-469.
34. Polihronis M., Tapinos N.I., Theocharis S.E., Economou A., Kittas C., Moutsopoulos H.M. Modes of epithelial cell death and repair in Sjogren's syndrome (SS). Clin Exp Immunol 1998, 114:485-490.
35. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
36. Kapsogeorgou E.K., Abu-Helu R.F., Moutsopoulos H.M., Manoussakis M.N. Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum 2005, 52:1517-1521.
37. Dimitriou I.D., Kapsogeorgou E.K., Abu-Helu R.F., Moutsopoulos H.M., Manoussakis M.N. Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. Eur J Oral Sci 2002, 110:21-30.
38. Skopouli F.N., Kousvelari E.E., Mertz P., Jaffe E.S., Fox P.C., Moutsopoulos H.M. c-myc mRNA expression in minor salivary glands of patients with Sjogren's syndrome. J Rheumatol 1992, 19:693-699.
39. Yannopoulos D.I., Roncin S., Lamour A., Pennec Y.L., Moutsopoulos H.M., Youinou P. Conjunctival epithelial cells from patients with Sjogren's syndrome inappropriately express major histocompatibility complex molecules, La(SSB) antigen, and heat-shock proteins. J Clin Immunol 1992, 12:259-265.
40. Fye K.H., Terasaki P.I., Michalski J.P., Daniels T.E., Opelz G., Talal N. Relationshipp of HLA-Dw3 and HLA-B8 to Sjogren's syndrome. Arthritis Rheum 1978, 21:337-342.
41. Mann D.L., Moutsopoulos H.M. HLA DR alloantigens in different subsets of patients with Sjogren's syndrome and in family members. Ann Rheum Dis 1983, 42:533-536.
42. Reveille J.D., Macleod M.J., Whittington K., Arnett F.C. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol 1991, 146:3871-3876.
43. Scofield R.H. Genetics of systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 2009, 21:448-453.
44. Miceli-Richard C., Comets E., Loiseau P., Puechal X., Hachulla E., Mariette X. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum 2007, 56:3989-3994.
45. Nordmark G., Kristjansdottir G., Theander E., Eriksson P., Brun J.G., Wang C., et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome. Genes Immun 2009, 10:68-76.
46. Hjelmervik T.O., Petersen K., Jonassen I., Jonsson R., Bolstad A.I. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum 2005, 52:1534-1544.
47. Gottenberg J.E., Cagnard N., Lucchesi C., Letourneur F., Mistou S., Lazure T., et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci U S A 2006, 103:2770-2775.
48. Mariette X., Zerbib M., Jaccard A., Schenmetzler C., Danon F., Clauvel J.P. Hepatitis C virus and Sjogren's syndrome. Arthritis Rheum 1993, 36:280-281.
49. Kordossis T., Paikos S., Aroni K., Kitsanta P., Dimitrakopoulos A., Kavouklis E., et al. Prevalence of Sjogren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology. Br J Rheumatol 1998, 37:691-695.
50. Shillitoe E.J., Daniels T.E., Whitcher J.P., Vibeke Strand C., Talal N., Greenspan J.S. Antibody to cytomegalovirus in patients with Sjogren's syndrome. As determined by an enzyme-linked immunosorbent assay. Arthritis Rheum 1982, 25:260-265.
51. Venables P.J., Ross M.G., Charles P.J., Melsom R.D., Griffiths P.D., Maini R.N. A seroepidemiological study of cytomegalovirus and Epstein-Barr virus in rheumatoid arthritis and sicca syndrome. Ann Rheum Dis 1985, 44:742-746.
52. Fox R.I., Pearson G., Vaughan J.H. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. J Immunol 1986, 137:3162-3168.
53. Saito I., Servenius B., Compton T., Fox R.I. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med 1989, 169:2191-2198.
54. Talal N., Dauphinee M.J., Dang H., Alexander S.S., Hart D.J., Garry R.F. Detection of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome (autoimmune exocrinopathy). Arthritis Rheum 1990, 33:774-781.
55. Brookes S.M., Pandolfino Y.A., Mitchell T.J., Venables P.J., Shattles W.G., Clark D.A., et al. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 1992, 31:735-742.
56. Saito I., Nishimura S., Kudo I., Fox R.I., Moro I. Detection of Epstein-Barr virus and human herpes virus type 6 in saliva from patients with lymphoproliferative diseases by the polymerase chain reaction. Arch Oral Biol 1991, 36:779-784.
57. Shattles W.G., Brookes S.M., Venables P.J., Clark D.A., Maini R.N. Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjogren's syndrome. Clin Exp Immunol 1992, 89:46-51.
58. Couty J.P., Ranger-Rogez S., Vidal E., Rogez J.P., Denis F. Study of HHV-8 in primary Sjogren's syndrome. Clin Exp Rheumatol 1997, 15:333-334.
59. Triantafyllopoulou A., Tapinos N., Moutsopoulos H.M. Evidence for coxsackievirus infection in primary Sjogren's syndrome. Arthritis Rheum 2004, 50:2897-2902.
60. Leimola-Virtanen R., Salo T., Toikkanen S., Pulkkinen J., Syrjanen S. Expression of estrogen receptor (ER) in oral mucosa and salivary glands. Maturitas 2000, 36:131-137.
61. Tsinti M., Kassi E., Korkolopoulou P., Kapsogeorgou E., Moutsatsou P., Patsouris E., et al. Functional estrogen receptors alpha and beta are expressed in normal human salivary gland epithelium and apparently mediate immunomodulatory effects. Eur J Oral Sci 2009, 117:498-505.
62. Kassi E., Moutsatsou P., Sekeris C.E., Moutsopoulos H.M., Manoussakis M.N. Oestrogen receptors in cultured epithelial cells from salivary glands of Sjogren's syndrome patients. Rheumatology (Oxford) 2003, 42:1120-1122.
63. Ishimaru N., Arakaki R., Watanabe M., Kobayashi M., Miyazaki K., Hayashi Y. Development of autoimmune exocrinopathy resembling Sjogren's syndrome in estrogen-deficient mice of healthy background. Am J Pathol 2003, 163:1481-1490.
64. Carlsten H., Nilsson N., Jonsson R., Backman K., Holmdahl R., Tarkowski A. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol 1992, 144:190-202.
65. Ishimaru N., Saegusa K., Yanagi K., Haneji N., Saito I., Hayashi Y. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through fas-mediated apoptosis. Am J Pathol 1999, 155:173-181.
66. Shim G.J., Warner M., Kim H.J., Andersson S., Liu L., Ekman J., et al. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc Natl Acad Sci U S A 2004, 101:12628-12633.
67. Tzarouchi L.C., Tsifetaki N., Konitsiotis S., Zikou A., Astrakas L., Drosos A., et al. CNS involvement in primary Sjogren Syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometry. AJR Am J Roentgenol 2011, 197:1207-1212.
68. Yoshimoto K., Tanaka M., Kojima M., Setoyama Y., Kameda H., Suzuki K., et al. Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjogren's syndrome. Arthritis Res Ther 2011, 13:R170.
69. Baugh M., Black D., Westwood P., Kinghorn E., McGregor K., Bruin J., et al. Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity. J Autoimmun 2011, 36:201-209.
70. Luckey D., Bastakoty D., Mangalam A.K. Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice. J Autoimun 2011, 37:122-128.
71. Sharma R., Sung S.S., Ju C.Y., Deshmukh U.S., Fu S.M., Ju S.T. Regulatory T-cell (Treg) hybridoma as a novel tool to study Foxp3 regulation and Treg fate. J Autoimun 2011, 37:113-121.
72. Lemoine S., Morva A., Youinou P., Jamin C. Human T cells induce their own regulation through activation of B cells. J Autoimmun 2011, 36:228-238.
73. Ge X., James E.A., Reijonen H., Kwok W.W. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes. J Autoimmun 2011, 36:155-160.
74. Gilboa-Geffen A., Wolf Y., Hanin G., Melamed-Book N., Pick M., Bennett E.R., et al. Activation of the alternative NFκ pathway improves disease symptoms in a model of Sjogren's syndrome. PLoS One 2011, 6:e28727.
75. Ng W.F. Primary Sjogren's syndrome research and therapy: has a new dawn arrived?. Curr Pharm Biotechnol 2012, [Epub ahead of print].
76. Dantec C.L., Varin M.M., Brooks W.H., Pers J.O., Youinou P., Renaudineau Y. Epigenetics and Sjogren's syndrome. Curr Pharm Biotechnol 2012, [Epub ahead of print].
77. Gottenberg J.E., Mariette X. Primary Sjogren's syndrome: time for prospective cohorts. Curr Pharm Biotechnol 2012, [Epub ahead of print].
78. Youinou P., Saraux A., Pers J.O. B-lymphocytes govern the pathogenesis of Sjogren's syndrome. Curr Pharm Biotechnol 2012, [Epub ahead of print].
79. Naiyanetr P., Butler J.D., Meng L., Pfeiff J., Kenny T.P., Guggenheim K.G., et al. Electrophile-modified lipoic acid derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. J Autoimmun 2011, 37:209-216.
80. Wang Y.L., Chou F.C., Chen S.J., Lin S.H., Chang D.M., Sytwu H.K. Targeting pre-ligand assembly domain of TNFR1 ameliorates autoimmune diseases-an unrevealed role in downregulation of Th17 cells. J Autoimmun 2011, 37:160-170.